Komori
Sokensha (7413) · FactUpdated sales results

Extraordinary Income from the Sale of Investment Securities

First written in FY2022-Q2. 1 of 5 entries say "Restated". Latest entry: FY2023.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q2 – FY20232021: 120212022: 220222023: 22023
Same theme, other companies
Recognition of gains on sales of investment securities and shares in affiliated companiesA theme 374 companies write about · 1 as a headwind · 396 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 183 companies compared. The sentences above are computed from all 183.Comparing 200 of the theme's 401 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023Updated sales resultsAnnual report

    「Although proceeds of ¥33 million were received from the sale of investment securities, cash used amounted to ¥2 million due mainly to ¥21 million in expenditures for the acquisition of property, plant and equipment and ¥16 million in expenditures for contributions to insurance savings.」

    In the current fiscal year, proceeds of ¥500,000 from the sale of investment securities were recorded, updating the results from the previous fiscal year's sale proceeds of ¥33.6 million and gain on sale of ¥13.537 million.
  2. FY2023-Q3Cited as achievedAnnual report

    「In the nine-month period ended December of the previous fiscal year, investment securities generated a gain on sale of ¥13 million, which we recorded as extraordinary income.」

    The ¥13 million gain on the sale of investment securities in the nine-month period ended December of the previous fiscal year is reproduced as comparative information from prior-period results.
  3. FY2022Additional disclosure of sale proceedsAnnual report

    「Although proceeds of ¥33 million were received from the sale of investment securities, cash used amounted to ¥2 million due mainly to ¥21 million in expenditures for the acquisition of property, plant and equipment and ¥16 million in expenditures for contributions to insurance savings.」

    The company disclosed full-year results showing the sale of investment securities for ¥33 million and the recording of a ¥13.537 million gain on sale as extraordinary income.
  4. FY2022-Q3RestatedAnnual report

    「In addition, as investment securities generated a gain on sale of ¥13 million during the nine-month period ended December 2024, we recorded it as extraordinary income.」

    The company reconfirmed the recording of a ¥13 million gain on the sale of investment securities as extraordinary income in the nine-month period ended December 2024.
  5. FY2022-Q2First statedAnnual report

    「In addition, as investment securities generated a gain on sale of ¥13 million during the six-month period ended September 2024, we recorded it as extraordinary income.」

    The company disclosed that it recorded a ¥13 million gain on the sale of investment securities as extraordinary income.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Sokensha's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.